These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11165138)

  • 21. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.
    Pallares J; Bussaglia E; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Sanchez-Verde L; Palacios J; Prat J; Matias-Guiu X
    Mod Pathol; 2005 May; 18(5):719-27. PubMed ID: 15578076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN expression is a strong predictor of survival in mesothelioma patients.
    Opitz I; Soltermann A; Abaecherli M; Hinterberger M; Probst-Hensch N; Stahel R; Moch H; Weder W
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):502-6. PubMed ID: 18248818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the PTEN tumour suppressor protein during human development.
    Gimm O; Attié-Bitach T; Lees JA; Vekemans M; Eng C
    Hum Mol Genet; 2000 Jul; 9(11):1633-9. PubMed ID: 10861290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
    Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM
    Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression.
    Fenic I; Franke F; Failing K; Steger K; Woenckhaus J
    J Pathol; 2004 May; 203(1):559-66. PubMed ID: 15095479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
    Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTEN mutations are common in sporadic microsatellite stable colorectal cancer.
    Nassif NT; Lobo GP; Wu X; Henderson CJ; Morrison CD; Eng C; Jalaludin B; Segelov E
    Oncogene; 2004 Jan; 23(2):617-28. PubMed ID: 14724591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
    Kulke MH; Odze RD; Thakore KS; Thomas G; Wang H; Loda M; Eng C
    Br J Cancer; 2001 Mar; 84(6):748-53. PubMed ID: 11259087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN function: how normal cells control it and tumour cells lose it.
    Leslie NR; Downes CP
    Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
    Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
    Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
    McMenamin ME; Soung P; Perera S; Kaplan I; Loda M; Sellers WR
    Cancer Res; 1999 Sep; 59(17):4291-6. PubMed ID: 10485474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation.
    Ghosh AK; Grigorieva I; Steele R; Hoover RG; Ray RB
    Gene; 1999 Jul; 235(1-2):85-91. PubMed ID: 10415336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
    Weng LP; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.